A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Severe to Very Severe Alopecia Areata in Adult Patients (Rezolve AA)
Clinical trial NCT06340360 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06340360
- Sponsor
- Nektar Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-02
- Primary completion
- 2025-11-26
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.